SEC Filings

Filing date	Form	Description	View
Nov 04, 2025	SCHEDULE 13G/A	SCHEDULE 13G/A - Description	0001172661-25-004562.pdf 0001172661-25-004562.rtf 0001172661-25-004562.xls View HTML
Nov 03, 2025	SCHEDULE 13G	SCHEDULE 13G - Description	0001172661-25-004537.pdf 0001172661-25-004537.rtf 0001172661-25-004537.xls View HTML
Oct 24, 2025	SCHEDULE 13D	SCHEDULE 13D - Description	0001486180-25-000006.pdf 0001486180-25-000006.rtf 0001486180-25-000006.xls View HTML
Sep 22, 2025	8-K	Report of unscheduled material events or corporate event	0001104659-25-092162.pdf 0001104659-25-092162.rtf 0001104659-25-092162.xls EX-101.SCH - XBRL TAXONOMY EXTENSION SCHEMA View HTML
Aug 27, 2025	4	Statement of changes in beneficial ownership of securities	0000905148-25-003155.pdf 0000905148-25-003155.rtf 0000905148-25-003155.xls View HTML
Aug 26, 2025	S-8	Securities offered to employees pursuant to employee benefit plans	0001104659-25-083112.pdf 0001104659-25-083112.rtf 0001104659-25-083112.xls View HTML
Aug 13, 2025	4	Statement of changes in beneficial ownership of securities	0000905148-25-002876.pdf 0000905148-25-002876.rtf 0000905148-25-002876.xls View HTML
Aug 13, 2025	4	Statement of changes in beneficial ownership of securities	0000905148-25-002875.pdf 0000905148-25-002875.rtf 0000905148-25-002875.xls View HTML
Aug 13, 2025	4	Statement of changes in beneficial ownership of securities	0000905148-25-002877.pdf 0000905148-25-002877.rtf 0000905148-25-002877.xls View HTML
Aug 13, 2025	4	Statement of changes in beneficial ownership of securities	0000905148-25-002874.pdf 0000905148-25-002874.rtf 0000905148-25-002874.xls View HTML

Data provided by Kaleidoscope.

Electroporation Systems

ATX_01

ATx

From small to medium static Electroporation.

STX_01

STx

Transfect up to 20 billion cells with scalable static or Flow Electroporation®.

GTx

GTx

Transfect up to 20 billion cells with our clinically validated and cGMP compliant Flow Electroporation®.

VLX

VLx

For gram scale protein production.

Our Electroporation Technology

Processing Assemblies

Processing Assemblies

Achieve the desired scale and throughput with a range of consumable devices.

Accessories & Reagents

Reagents & Supporting Products

Complement your workflow with our flexible electroporation buffer formats and accessories.

Cell Therapy

Discover scalable engineering to enable safe and potent cell therapies.

Gene Editing

Navigate the complexities of genome engineering with highly efficient delivery.

Protein & Antibody Production

Accelerate biotherapeutic development with transient expression for gram-scale protein production.

Cell Based Assays

Produce assay-ready cells faster with scalable electroporation.

Viral Vector

Transfect adherent or suspension cells to produce a variety of viral vectors.

Vaccine Development

Innovate vaccine research with our adaptable platform for production of recombinant proteins, virus-like particles.

Industries

Cell & Gene Therapy

Partnering with developers to accelerate development and scale cell therapy programs toward clinical success.

Discovery & Translational Research

Accelerating breakthrough discoveries with high-efficiency, reproducible electroporation across cell types.

Bioprocessing

Enabling efficient, reproducible transfection in virtually any cell type for high-yield transient expression and rapid cell line development.